Cellectis (CLLS) Invested Capital (2014 - 2026)
Cellectis' Invested Capital was $107.25 million in Q2 2026, down 29.9% from $152.97 million a year earlier and down 15.8% from the prior quarter.
Powered by 
Analysis
Cellectis (CLLS) Invested Capital (2014 - 2026) Analysis & Trends
For FY2025, Invested Capital at Cellectis came in at $149.91 million, down 17.6% from FY2024.
- Invested Capital shows a five-year compound annual growth rate of -15.0% (FY2020 to FY2025).
- In earlier years, Invested Capital was $181.92 million in FY2024 (+26.4%), $143.92 million in FY2023 (-1.7%), $146.47 million in FY2022 (-42.9%) and $256.5 million in FY2021 (-24.0%).
- The Q2 2026 figure marks the lowest quarterly Invested Capital in data going back to Q4 2015.
- Compared with a year earlier, Invested Capital has declined for five straight quarters, with growth averaging 1.7% over the last eight quarters.
- The best year-over-year quarter for Invested Capital over five years was Q3 2024 (growth of 142.3%); the worst was Q2 2025 (a decline of 49.6%).
- Per Business Quant data, CLLS's Invested Capital in the three quarters before Q2 2026 was $127.42 million (Q1 2026), $149.91 million (Q4 2025) and $163.88 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Invested Cap. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 89.77 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 126.18 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 76.32 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 98.72 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 45.14 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 68.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 39.27 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 151.97 Bn |
| 10 | Cellectis | 111.38 Mn | -642.02 Mn | - | 114.75 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 114.75 Mn |
| Mar 31, 2026 | 136.32 Mn |
| Dec 31, 2025 | 160.37 Mn |
| Sep 30, 2025 | 182.12 Mn |
| Jun 30, 2025 | 171.20 Mn |
| Mar 31, 2025 | 184.03 Mn |
| Dec 31, 2024 | 198.05 Mn |
| Sep 30, 2024 | 196.35 Mn |
| Jun 30, 2024 | 212.08 Mn |
| Mar 31, 2024 | 158.36 Mn |
| Dec 31, 2023 | 139.11 Mn |
| Sep 30, 2023 | 124.43 Mn |
| Jun 30, 2023 | 142.01 Mn |
| Mar 31, 2023 | 138.55 Mn |
| Dec 31, 2022 | 151.56 Mn |
| Sep 30, 2022 | 161.72 Mn |
| Jun 30, 2022 | 207.47 Mn |
| Mar 31, 2022 | 222.00 Mn |
| Dec 31, 2021 | 258.86 Mn |
| Sep 30, 2021 | 260.73 Mn |
API Access
Cellectis Invested Capital API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=invested-capital&ticker=CLLS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "invested-capital", "ticker": "CLLS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=invested-capital&ticker=CLLS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();